Complex vulnerabilities as barriers to treatment for illicit drug users with high prevalence mental health co-morbidities

Mental Health and Substance Use: Dual Diagnosis

Volumn 1, Issue 1, 2008, Pages 84-95

  Treloar, Carla ^a   Holt, Martin ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Barriers; Complex needs; Drug treatment; Mental health; Qualitative research

Indexed keywords

EID: 56849110083     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523280701759755     Document Type: Article

References (33)

1. Callaly, T., Trauer, T., Munro, L., and Whelan, G., 2001. Prevalence of psychiatric disorder in a methadone maintenance population. Australian and New Zealand Journal of Psychiatry, 35:601–605.
2. Digiusto, E., Shakeshaft, A., Ritter, A., Mattick, R., White, J., Lintzeris, N., 2006. Effects of pharmacotherapies for opioid dependence on participants' criminal behaviour and expenditure on illicit drugs:An Australian national evaluation (NEPOD). The Australian and New Zealand Journal of Criminology, 39:171–189.
3. Fiorentine, R., Nakashima, J., and Anglin, M. D., 1999. Client engagement in drug treatment. Journal of Substance Abuse Treatment, 17:199–206.
4. Glaser, B., and Strauss, A., 1967. Discovery of grounded theory:Strategies for qualitative research, Chicago:Aldine de Gruyter.
5. Gowing, L., Proudfoot, H., Henry-Edwards, S., and Teesson, M., 2001. Evidence supporting treatment:The effectiveness of interventions for illicit drug use, Canberra:Australian National Council on Drugs.
6. Greig, R., Baker, A., Lewin, T., Webster, R., and Carr, V. J., 2006. Long-term follow-up of people with co-existing psychiatric and substance use disorders:patterns of use and outcomes. Drug and Alcohol Review, 25:249–258.
7. Hall, W., 1996. What have population surveys revealed about substance use disorders and their co-morbidity with other mental disorders?. Drug and Alcohol Review, 15:157–170.
8. Holloway, K., Bennett, T., and Farrington, D., 2006. The effectiveness of drug treatment programs in reducing criminal behavior:A meta-analysis. Psicothema, 18:620–629.
9. Holt, M., 2007. Agency and dependency within treatment:Drug treatment clients negotiating methadone and antidepresstants. Social Science & Medicine, 64:1937–1947.
10. Hser, Y.-I., Polinsky, M. L., Maglione, M., and Anglin, M. D., 1999. Matching clients' needs with drug treatment services. Journal of Substance Abuse Treatment, 16:299–305.
11. Kertesz, S., Larson, M., Cheng, D., Tucker, J., Winter, M., Mullins, A., 2006. Need and non-need factors associated with addiction treatment utilization in a cohort of homeless and housed urban poor. Medical Care, 44:225–233.
12. Knight, D., Wallace, G., Joe, G., and Logan, S., 2001. Change in psychosical functioning and social relations among women in residential substance abuse treatment. Journal of Substance Abuse, 13:533–547.
13. Luthar, S., and Cicchetti, D., 2000. The construct of resilience:Implications for interventions and social policies. Development and Psychopathology, 12:857–885.
14. Manns, L., 2003. “ Comorbidity:why does it matter? (A consumer perspective) ”. In Comorbid mental disorders and substance use disorders:Epidemiology, prevention and treatment, Edited by:Teeson, M., and Proudfoot, H., 143–146. Canberra:Australian Government Department of Health and Ageing.
15. Marmot, M., 1999. “ Introduction ”. In Social determinants of health, Edited by:Marmot, M., and Wilkinson, R., Oxford:Oxford University Press.
16. National Treatment Agency for Substance Misuse. 2006. User and carer involvement:Guidance notes to adult treatment plans 2007/08, London:National Treatment Agency for Substance Misuse.
17. Neale, J., 1998. Drug users' views of prescribed methadone. Drugs:Education, Prevention & Policy, 5:33–45.
18. Neale, J., 1999. Understanding drug-using clients' views of substitute prescribing. British Journal of Social Work, 29:127–145.
19. Patton, M., 2002. Qualitative research and evaluation methods, 3rd edn, Thousand Oaks, CA:Sage.
20. Potter, J., and Wetherell, M., 1987. Discourse and social psychology:Beyond attitudes and behaviour, London:Sage.
21. Proudfoot, H., Teesson, M., Brewin, E., and Gournay, K., 2003. “ Comorbidity and delivery of services ”. In Comorbid mental disorders and substance use disorders:Epidemiology, prevention and treatment, Edited by:Teeson, M., and Proudfoot, H., 121–142. Canberra:Australian Government Department of Health and Ageing.
22. Rivers, P., Dobalian, A., Oyana, T., and Bae, S., 2006. Socioeconomic determinants of planned methadone treatment. American Journal of Health Behavior, 30:451–459.
23. Select Committee on Mental Health. 2006. A national approach to mental health—from crisis to community:Final report, Canberra:Australian Senate.
24. Siegfried, N., Ferguson, J., Cleary, M., Walter, G., and Rey, J., 1999. Experience, knowledge and attitudes of mental health staff regarding patients' problematic drug and alcohol use. Australian and New Zealand Journal of Psychiatry, 33:267–273.
25. Siggins Miller Consultants. 2003. Current practice in the management of clients with comorbid mental health and substance use disorders in tertiary care settings, Canberra:Commonwealth Department of Health and Ageing.
26. Tedeschi, R., and Kilmer, R., 2005. Assessing strengths, resilience, and growth to guide clinical interventions. Professional Psychology:Research and Practice, 36:230–237.
27. Teesson, M., Hall, W., Lynskey, M., and Degenhardt, L., 2000. Alcohol- and drug-use disorders in Australia:Implications of the National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 34:206–213.
28. Teesson, M., Havard, A., Fairbairn, S., Ross, J., Lynskey, M., and Darke, S., 2005. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS):Prevalence, correlates and treatment seeking. Drug & Alcohol Dependence, 78:309–315.
29. Treloar, C., Abelson, J., Cao, W., Brener, L., Kippax, S., Schultz, L., 2004. Barriers and incentives to treatment for illicit drug users, Canberra:Commonwealth Department of Health and Ageing.
30. Treloar, C., Fraser, S., and Valentine, K., 2007. Valuing methadone take-away doses:The contribution of service user perspectives to policy and practice. Drugs:Education, Prevention & Policy, 14:61–74.
31. Treloar, C., and Holt, M., 2006. Deficit models and divergent philosophies:Service providers' perspectives on barriers and incentives to drug treatment. Drugs; Education, Prevention and Policy, 13 (4):367–382.
32. Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J., 2000. Social costs of untreated opioid dependence. Journal of Urban Health, 77:688–722.
33. Wood, E., Li, K., Palepu, A., Marsh, D., Schechter, M. T., Hogg, R. S., 2005. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. Substance Use & Misuse, 40:1153–1167.